Apixaban Versus Enoxaparin For Postoperative Thromboprophylaxis
International Journal of Enhanced Research in Medicines & Dental Care · 2026
DOI: 10.55948/ijermdc.13102601 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Enhanced Research in Medicines & Dental Care, 2026. Verfasst von Mr. A. Prathap und 4 weiteren Autor:innen.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Background
Postoperative venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a major complication following surgery. Pharmacological thromboprophylaxis is essential for reducing VTE risk. Enoxaparin, a low-molecular-weight heparin, is widely used, while apixaban provides an oral direct factor Xa inhibitor alternative.
Objective
To compare the efficacy, safety, advantages, and limitations of apixaban and enoxaparin for postoperative thromboprophylaxis.
Methods
Evidence from randomized controlled trials, comparative studies, systematic reviews, and clinical guidelines was reviewed, focusing on VTE prevention, bleeding outcomes, route of administration, renal function, treatment duration, and patient-related factors.
Results
Apixaban demonstrated effective VTE prevention with efficacy and bleeding outcomes broadly comparable to enoxaparin, particularly after major orthopedic surgery. Its oral administration offers greater convenience than subcutaneous enoxaparin.
Conclusion
Apixaban is an effective oral option in appropriately selected patients. Treatment should be individualized according to surgical procedure, thrombotic and bleeding risks, renal function, and current guidelines.
Zitieren
APA
Prathap, M. A., R, M., G, K., E, L., & T, M. (2026). Apixaban Versus Enoxaparin For Postoperative Thromboprophylaxis. International Journal of Enhanced Research in Medicines & Dental Care. https://doi.org/10.55948/ijermdc.13102601
Vancouver
Prathap MA, R M, G K, E L, T M. Apixaban Versus Enoxaparin For Postoperative Thromboprophylaxis. International Journal of Enhanced Research in Medicines & Dental Care. 2026. doi:10.55948/ijermdc.13102601
BibTeX
@article{Prathap2026,
author = {Prathap, Mr. A. and R, Mounisha and G, Krupadevi and E, Lavanya and T, Manisha},
title = {Apixaban Versus Enoxaparin For Postoperative Thromboprophylaxis},
journal = {International Journal of Enhanced Research in Medicines & Dental Care},
year = {2026},
doi = {10.55948/ijermdc.13102601}
}
EUVIMED